Suchergebnisse - "Domingo-Domenech, Eva"

PubPharm (10)

1

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL) : real-life experience with long-term outcomes, toxicities and responses to second-line therapies

enthalten in: International journal of hematology | 2023

von Oliveira, A. | Roncero, J. | Ferrá, C. | +10

2

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

enthalten in: Blood advances | 2022

von Savage, K. | Horwitz, S. | Advani, R. | +21

3

Synchronizing the use of allogeneic hematopoietic cell transplantation in checkpoint blockade therapy for Hodgkin lymphoma

enthalten in: Expert review of hematology | 2021

von Mussetti, A. | Bosch Vilaseca, A. | Parody, R. | +3

4

Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution

enthalten in: Leukemia & lymphoma | 2020

von Salas, M. | Mercadal, S. | Domingo Domenech, E. | +8

5

Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL) : results in a homogeneous series from a single institution

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2020

von Salas, M. | Climent, F. | Tapia, G. | +12

6

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Horwitz, S. | O'Connor, O. | Pro, B. | +129

CommentIn: Lancet. 2019 Jan 19;393(10168):201-202. - PMID 30663580

7

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma : 12 years follow-up of a phase 2 trial

enthalten in: Annals of hematology | 2017

von Magnano, L. | Montoto, S. | González-Barca, E. | +20

8

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients

enthalten in: Acta haematologica | 2016

von González-Barca, E. | Canales, M. | Salar, A. | +17

9

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma

enthalten in: Haematologica | 2008

von Montoto, S. | Moreno, C. | Domingo-Doménech, E. | +18

10

Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas

enthalten in: Haematologica | 2002

von Domingo-Domènech, E. | González-Barca, E. | Estany, C. | +3

1
[1]